Dr. Barbara is Professor of Internal Medicine and Gastroenterology at the University of Bologna. His research focuses on neurogastroenterology, brain-gut interactions, and the intestinal microenvironment (microbiota-host interactions). He is member of the Steering Committee of ESNM and member of the Board of Directors of the Rome Foundation. He holds the Master Award in Gastroenterology for Basic and Clinical Research in Digestive Science from the American Gastroenterological Association.
Research Director at the French National Research Institute for Agriculture, Food and the Environment, INRAE, Dr. Joël Doré is currently President of the Executive Committee of the Pre-Industrial Demonstrator MetaGenoPolis, a platform of excellence dedicated to quantitative and functional metagenomics, funded by the French government Futures Investments.by GMFH Editing Team
According to the Celiac Disease Foundation, celiac disease affects 1 in 100 people worldwide. To mark International Coeliac Day, GMFH interviews Dr Elena Verdú from McMaster University (Canada), who explains some key facts about the condition.
Daniel Pohl is Head of the Neurogastroenterology and Motility Unit at the University Hospital Zurich, Switzerland. Besides managing a very busy clinic his research interests include upper gut motility and dysmotility, nutrient intolerance and disorders of brain-gut interaction. Daniel is the co-founder of the Swiss Society of Neurogastroenterology and Motility (SwissNGM) and Member of the executive committee of the European Society of Neurogastroenterology and Motility (ESNM).Analysing the molecular and biochemical mechanisms disturbing the complex network of communication is key to our understanding of the pathophysiology of the functional GI disorders. Together with ESNM we have prepared an exciting webinar series under the topic: Microbiota and Gut-Brain Connection: A new Frontier in Neurogastroenterology. This free resource is a great opportunity to hear leading worldwide experts presenting the most recent findings on this topic.
by GMFH Editing Team
In 2020, we saw important scientific advances in our understanding of how the gut microbiome contributes to human health beyond the gastrointestinal milieu. Discover the year’s breakthroughs in this “2020 Year at a glance” report.
This year’s research has brought to light many interesting advances in the field of gut health and has unveiled some of the microbiota’s secrets. We have discussed the impact of diet, immunity, fermented foods, the characteristics of gut health, and of course we also covered COVID-19. So, can you guess what GMFH’s 10 most popular articles of 2020 were?
by GMFH Editing Team
Beyond antibiotics, a wide range of commonly used non-antibiotic drugs can affect the gut microbiome. In addition, the gut microbiome can also influence an individual’s response to drugs by affecting their efficacy and safety. What are the implications of the bidirectional interaction between non-antibiotic drugs and the gut microbiome in the clinical setting?
This infographic lets you find out more about Lactobacillus, one of gut microbiota’s main microorganisms, along with information on how it functions and in which foods it is present.
by GMFH Editing Team
Diet is becoming increasingly popular as a means of managing IBS symptoms. A new study in 95 adults with IBS examines diet-gut microbiota associations and concludes that baseline gut microbiota is not a good predictor of clinical response to a low FODMAP diet or probiotic intervention.
